NCT02302365View on ClinicalTrials.gov

Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions

Leukocytosis

Interventions

DEVICE

Spectra Optia® Apheresis System

White Blood Cell Depletion

Trial Locations (3)

1097

Szent Istvan and Szent Laszlo Hospital of Budapest, Budapest

3000

UZ Gasthuisberg, Leuven

60528

Institute for Transfusion Medicine and Immunohaematology, German Red Cross Blood Donor Service Baden-Württemberg-Hessen gGmbH, Johann-Wolfgang-Goethe-University Hospital, Frankfurt am Main

All Listed Sponsors

lead

Terumo BCT

INDUSTRY

NCT02302365 - Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion | Biotech Hunter | Biotech Hunter